News Industry News Biosense Webster Launches New Version of CARTO™ 3 Electro-Anatomical Mapping System May 08, 2024
News Industry News Medtronic TYRX™ Absorbable Antibacterial Envelope Is Effective at Reducing Infections in Cardiac Device Patients with Hematomas July 26, 2021
News Industry News Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality August 16, 2019
News Industry News New study finds both components of blood pressure predict heart attack, stroke risk July 17, 2019
News Industry News New Study Finds Abbott Blood Test Can Help Predict Future Cardiac Events In Adults With No Known Heart Disease April 29, 2019
News Industry News Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease April 11, 2018
News Industry News AUM Cardiovascular Receives FDA Approval For Revolutionary Diagnostic Heart Device August 08, 2017
News Industry News Abbott Initiates Clinical Trial of Three-Month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent July 25, 2017
News Industry News New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints May 12, 2017
News Industry News SoundBite Initiates Human Clinical Studies for Peripheral CTO Crossing Procedures December 01, 2016
News Industry News Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance November 01, 2016
News Industry News Angionetics' Generx® [Ad5FGF-4] Gene Therapy Biologic Receives FDA Clearance For U.S. Phase 3 Clinical Study As A New, Single Dose, Treatment For Coronary Artery Disease September 12, 2016
News Industry News Secondary Analysis of EXAMINE Trial Finds Highest Risk of Cardiovascular Death for Patients Previously Hospitalized with Heart Failure June 13, 2016
News Industry News New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control March 01, 2016
News Industry News AtriCure Enrolls First Patient in Randomized Multi-Center Trial Evaluating Post-Operative Afib February 17, 2016
News Industry News One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015 October 20, 2015
News Industry News Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial August 03, 2015